West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,893,200 | 2,949,800 | 2,886,900 | 2,831,600 | 2,146,900 |
| Cost of Goods | 1,894,700 | 1,820,600 | 1,750,700 | 1,655,800 | 1,379,100 |
| Gross Profit | 998,500 | 1,129,200 | 1,136,200 | 1,175,800 | 767,800 |
| Operating Expenses | 429,300 | 453,800 | 402,900 | 424,300 | 361,000 |
| Operating Income | 569,900 | 676,000 | 734,000 | 752,300 | 406,900 |
| Interest Expense | 3,000 | 9,000 | 7,900 | 8,200 | 8,200 |
| Other Income | 33,300 | 48,700 | -25,500 | 24,900 | 20,000 |
| Pre-tax Income | 600,200 | 715,700 | 700,600 | 769,000 | 418,700 |
| Income Tax | 107,500 | 122,300 | 114,700 | 107,200 | 72,500 |
| Net Income Continuous | 492,700 | 593,400 | 585,900 | 661,800 | 346,200 |
| Net Income | $492,700 | $593,400 | $585,900 | $661,800 | $346,200 |
| EPS Basic Total Ops | 6.75 | 7.98 | 7.87 | 8.89 | 4.68 |
| EPS Basic Continuous Ops | 6.75 | 7.99 | 7.88 | 8.90 | 4.68 |
| EPS Diluted Total Ops | 6.69 | 7.88 | 7.73 | 8.67 | 4.57 |
| EPS Diluted Continuous Ops | 6.69 | 7.88 | 7.73 | 8.67 | 4.57 |
| EPS Diluted Before Non-Recurring Items | 6.75 | 8.08 | 8.58 | 8.58 | 4.76 |
| EBITDA(a) | $725,300 | $813,300 | $854,600 | $874,600 | $516,000 |